Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Semaglutide, a GLP-1 receptor agonist marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management, does not damage or permanently impair metabolic function
Some patients may use these medications for months, while others continue for years
Weekly Injections Administered subcutaneously at home or in-clinictraining provided by staff
While eating less is expected, going long hours without food can sometimes leave you feeling tired or low on energy
Workspan Daily article Strategies to Deliver Diabetes Support and Solutions for Employees, Workspan Daily article Fifty-one percent of employers in a recent benefits study cited glucagon-like peptide-1 (GLP-1) diabetes and weight-loss medications as the top driver of prescription drug spend, surpassing even cancer and autoimmune treatments
US$ 24.44
US$ 27.71
US$ 24.32
